Moreover, our findings confirmed that the high expression of FZD1/2/5/6/7/8 was a disadvantageous factor in glioma, while FZD2 and FZD6 could positively serve as independent predictors of poor prognosis. Here, FZD6 is linked to central nervous system cancer.